1.
Nielsen TB, Hansen O, Schytte T, Brink C. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose. AO [Internet]. 2014 Jan. 1 [cited 2026 May 3];53(1):119-25. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26951